GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (FRA:QTS) » Definitions » Shiller PE Ratio

IQVIA Holdings (FRA:QTS) Shiller PE Ratio : (As of May. 04, 2024)


View and export this data going back to 2013. Start your Free Trial

What is IQVIA Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


IQVIA Holdings Shiller PE Ratio Historical Data

The historical data trend for IQVIA Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Shiller PE Ratio Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 99.02 59.73 57.13

IQVIA Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.36 59.91 50.68 57.13 61.41

Competitive Comparison of IQVIA Holdings's Shiller PE Ratio

For the Diagnostics & Research subindustry, IQVIA Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Shiller PE Ratio falls into.



IQVIA Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

IQVIA Holdings's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, IQVIA Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.435/129.4194*129.4194
=1.435

Current CPI (Mar. 2024) = 129.4194.

IQVIA Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.471 100.560 0.606
201409 0.551 100.428 0.710
201412 0.560 99.070 0.732
201503 0.628 99.621 0.816
201506 0.597 100.684 0.767
201509 0.793 100.392 1.022
201512 0.780 99.792 1.012
201603 0.790 100.470 1.018
201606 0.632 101.688 0.804
201609 0.731 101.861 0.929
201612 -0.702 101.863 -0.892
201703 0.402 102.862 0.506
201706 0.249 103.349 0.312
201709 0.336 104.136 0.418
201712 4.242 104.011 5.278
201803 0.260 105.290 0.320
201806 0.248 106.317 0.302
201809 0.249 106.507 0.303
201812 0.299 105.998 0.365
201903 0.257 107.251 0.310
201906 0.266 108.070 0.319
201909 0.263 108.329 0.314
201912 0.081 108.420 0.097
202003 0.380 108.902 0.452
202006 -0.107 108.767 -0.127
202009 0.441 109.815 0.520
202012 0.501 109.897 0.590
202103 0.916 111.754 1.061
202106 0.747 114.631 0.843
202109 1.139 115.734 1.274
202112 1.443 117.630 1.588
202203 1.525 121.301 1.627
202206 1.268 125.017 1.313
202209 1.505 125.227 1.555
202212 1.133 125.222 1.171
202303 1.429 127.348 1.452
202306 1.468 128.729 1.476
202309 1.527 129.860 1.522
202312 2.329 129.419 2.329
202403 1.435 129.419 1.435

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IQVIA Holdings  (FRA:QTS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


IQVIA Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings (FRA:QTS) Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.